In Vitro Activity of Finafloxacin against Panels of Respiratory Pathogens

This study determined the in vitro activity of finafloxacin against panels of bacterial strains, representative of those associated with infection in cystic fibrosis patients and predominately isolated from clinical cases of respiratory disease. Many of these isolates were resistant to various antim...

Descripción completa

Detalles Bibliográficos
Autores principales: Harding, Sarah V., Barnes, Kay B., Hawser, Stephen, Bentley, Christine E., Vente, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376497/
https://www.ncbi.nlm.nih.gov/pubmed/37508192
http://dx.doi.org/10.3390/antibiotics12071096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376497/
https://www.ncbi.nlm.nih.gov/pubmed/37508192
http://dx.doi.org/10.3390/antibiotics12071096

Ejemplares similares